Metagenomi, Inc.
MGX
$1.86
-$0.05-2.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.49% | -7.01% | -24.64% | -74.81% | 57.30% |
| Total Depreciation and Amortization | -1.69% | -7.05% | 7.11% | 4.20% | 2.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 68.66% | -71.96% | 234.35% | -14.04% | -21.64% |
| Change in Net Operating Assets | -248.33% | 85.26% | -23.12% | 39.49% | -90.15% |
| Cash from Operations | 6.97% | 13.07% | 1.36% | -1.25% | 11.86% |
| Capital Expenditure | 55.90% | 13.77% | 72.17% | -80.45% | 27.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.40% | -13.38% | 473.40% | 37.48% | 86.81% |
| Cash from Investing | -22.87% | -13.37% | 419.51% | 31.47% | 86.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 75.79% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -257.14% | -- | -- | -- | -- |
| Cash from Financing | -115.58% | -- | 100.00% | 75.79% | -102.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -229.63% | -20.27% | 106.29% | 12.84% | -8.76% |